TriSalus Life Sciences TLSI
NASDAQ TLSI
$4.32 +0.17 (+4.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

TriSalus Life Sciences (TLSI) Gains from Sales and Divestitures (2022 - 2026)

Updated

TriSalus Life Sciences (TLSI) posted Gains from Sales and Divestitures of -$1,000 for Q1 2026, compared with -$117,000 a year earlier.

Analysis

TriSalus Life Sciences (TLSI) Gains from Sales and Divestitures (2022 - 2026) Analysis & Trends

For FY2025, TriSalus Life Sciences' Gains from Sales and Divestitures came in at -$120,000.

  • In prior years, TriSalus Life Sciences' Gains from Sales and Divestitures was -$23,000 in FY2024, -$44,000 in FY2023 and -$310,000 in FY2022.
  • The Q1 2026 figure stands as the highest quarterly Gains from Sales and Divestitures since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 TriSalus Life Sciences 265.55 Mn 119.58 Mn 9.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,000.00
Dec 31, 2025 -3,000.00
Mar 31, 2025 -117,000.00
Dec 31, 2024 -5,000.00
Mar 31, 2024 -18,000.00
Dec 31, 2023 16,000.00
Jun 30, 2023 -44,000.00
Mar 31, 2023 -16,000.00
Dec 31, 2022 -260,000.00
API Access

TriSalus Life Sciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TLSI&period=max&api_key=YOUR_API_KEY